Wnt-8a Antibodies

Santa Cruz Biotechnology offers a broad range of Wnt-8a monoclonal antibodies for research focused on understanding the Wnt signaling pathway. Wnt-8a Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Wnt-8a is a key member of the Wnt family, playing significant roles in cell signaling, development, and differentiation. Wnt-8a regulates embryonic development and has been linked to various diseases, including cancer. Research into Wnt-8a continues to reveal new insights about cellular processes and potential therapeutic approaches. Scientists can utilize Wnt-8a monoclonal antibodies to investigate signaling mechanisms in both normal and disease states. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization and quantification of Wnt-8a. Ongoing studies of Wnt-8a expression patterns and interactions contribute valuable knowledge to developmental biology and cancer research. Santa Cruz Biotechnology monoclonal antibodies support the scientific community's efforts to advance understanding of Wnt signaling pathways and their therapeutic potential.